(Q48387928)

11 February 2018

title

Metal chelates of L-DOPA for improved replenishment of dopaminergic pools (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1268731

7 September 2022

Metal chelates of l-DOPA for improved replenishment of dopaminergic pools (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

16 November 2023

1 reference

K. S. Rajan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1268731

7 September 2022

A. A. Manian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1268731

7 September 2022

J. M. Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1268731

7 September 2022

H. Dekirmenjian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1268731

7 September 2022

language of work or name

English

0 references

publication date

1 May 1976

1 reference

11 February 2018

7 May 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1268731

full work available at URL

7 September 2022

https://api.elsevier.com/content/article/PII:0006899376902298?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

https://api.elsevier.com/content/article/PII:0006899376902298?httpAccept=text/plain

16 November 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

16 November 2023

1 reference

11 February 2018

volume

107

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

317-331

1 reference

11 February 2018

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

16 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Copper(II) chelation by Dopa, epinephrine, and other catechols

16 November 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

The metabolism of orally administered l-DOPA in Parkinsonism

16 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

ANALYSIS OF THE MG++-ATP DEPENDENT STORAGE MECHANISM IN THE AMINE GRANULES OF THE ADRENAL MEDULLA

16 November 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Adenosine triphosphate--metal--norepinephrine ternary complexes and catecholamine binding.

16 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Co-ordination chemistry and membrane function with particular reference to the synapse and catecholamine transport.

16 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Aromatic Amino Acids and Modification of Parkinsonism

16 November 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Parkinsonism-dementia of Guam: Treatment with levodopa and L-alpha-methyldopahydrazine

16 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Uptake of Catecholamines by a Particulate Fraction of the Adrenal Medulla

16 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Carbidopa attenuation of L-dopa emesis in dogs: Evidence for a cerebral site of action outside the blood-brain barrier

16 November 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

16 November 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Metal chelates in the storage and transport of neurotransmitters: interactions of metal ions with biogenic amines

16 November 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Metal chelates in the storage and transport of neurotransmitters: interactions of Cu2+ with ATP and biogenic amines.

16 November 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Metal chelates in the storage and transport of neurotransmitters: formation of mixed ligand chelates of Mg 2+ -ATP with biogenic amines

16 November 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Possible New Metabolites mediating Actions of L-Dopa

16 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Actions of levodopa and dopamine in the central nervous system.

16 November 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

Drug-Induced Changes of Extracerebral Dopa Metabolism in Man

16 November 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(76)90229-8

16 November 2023

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018